Empagliflozin-mediated protection of heparan sulfate-rich endothelial glycocalyx during vascular inflammation

Authors: Natalia Chorazy, Kamila Wojnar-Lason, Anna M. Gdula et al.
Publication: Biochemical Pharmacology
Published: Jul 1, 2026
Source: Crossref
Back to Search View Original Cite This Article

Related Articles

Patient's Satisfaction as a Subjective Criterion for Assessing the Quality of Work in Primary Level Healthcare Protection Units in Bosnia and Herzegovina

Lejla Zunic, Ahmed Novo et al. - Jan 2200

Read More
Protection of Health Workers, Patients and Facilities in Times of Violence – Report

Unknown - Mar 2104

Read More
Assouplissement de la législation de protection de l’emploi : plus d’attractivité ? plus de bien-être ?

Sophie Lecostey - Jan 2030

Read More
Crafting a sustainable future: the transformative power of blockchain technology on social sustainability and organisational pride, mediated by business ethics and CSR authenticity

Tien Le Thi Cam - Jan 2028

Read More
Unveiling the Framework: a Case Study on Romania's Critical Infrastructure Protection Legislative System

Luiza Raduslav, Sorina Denisa Dragne et al. - Jan 2027

Read More